Naltrexone/Bupropion Combination Therapy in Overweight or Obese Patients With Major Depressive Disorder: Results of a Pilot Study

Objective: To evaluate the effect of 32-mg/d naltrexone sustained release and 360-mg/d bupropion sustained release (NB32) in overweight and obese patients with major depressive disorder (MDD). Method: Twenty-five female patients with a DSM-IV diagnosis of MDD, an Inventory of Depressive Symptomatolo...

Descripción completa

Detalles Bibliográficos
Autores principales: McElroy, Susan L., Guerdjikova, Anna I., Kim, Dennis D., Burns, Colleen, Harris-Collazo, Raúl, Landbloom, Ronald, Dunayevich, Eduardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Physicians Postgraduate Press, Inc. 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3795584/
https://www.ncbi.nlm.nih.gov/pubmed/24171147
http://dx.doi.org/10.4088/PCC.12m01494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3795584/
https://www.ncbi.nlm.nih.gov/pubmed/24171147
http://dx.doi.org/10.4088/PCC.12m01494

Ejemplares similares